[
    [
        {
            "time": "2023-10-10",
            "original_text": "华大基因现9笔大宗交易，共成交5,792.60万元",
            "features": {
                "keywords": [
                    "华大基因",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因现9笔大宗交易，共成交5,792.60万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "华大基因今日大宗交易成交52.66万股，成交价110.0元折价5.78%",
            "features": {
                "keywords": [
                    "华大基因",
                    "大宗交易",
                    "折价",
                    "成交量"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因今日大宗交易成交52.66万股，成交价110.0元折价5.78%",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-09-30",
            "original_text": "华大基因：截至2020年9月30日，公司股东总人数为57,439名",
            "features": {
                "keywords": [
                    "华大基因",
                    "股东人数",
                    "财报数据"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "华大基因：截至2020年9月30日，公司股东总人数为57,439名",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "华大基因：公司的海外业务实现快速增长，收入占比首次超过60%",
            "features": {
                "keywords": [
                    "华大基因",
                    "海外业务",
                    "收入增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技",
                    "国际化"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：公司的海外业务实现快速增长，收入占比首次超过60%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "明星股股价倒挂，睿远、高瓴惊出冷汗",
            "features": {
                "keywords": [
                    "明星股",
                    "股价倒挂",
                    "睿远",
                    "高瓴"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "机构投资",
                    "市场情绪"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "明星股股价倒挂，睿远、高瓴惊出冷汗",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "明星股股价倒挂，定增“旗手”睿远、高瓴惊出冷汗",
            "features": {
                "keywords": [
                    "明星股",
                    "股价倒挂",
                    "定增",
                    "睿远",
                    "高瓴"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "机构投资",
                    "市场情绪"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "明星股股价倒挂，定增“旗手”睿远、高瓴惊出冷汗",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]